Works matching AU Dimopoulos, Meletios-Athanasios

Results: 189
    1
    2

    Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin.

    Published in:
    Basic Research in Cardiology, 2025, v. 120, n. 1, p. 263, doi. 10.1007/s00395-024-01046-0
    By:
    • Efentakis, Panagiotis;
    • Choustoulaki, Angeliki;
    • Kwiatkowski, Grzegorz;
    • Varela, Aimilia;
    • Kostopoulos, Ioannis V.;
    • Tsekenis, George;
    • Ntanasis-Stathopoulos, Ioannis;
    • Georgoulis, Anastasios;
    • Vorgias, Constantinos E.;
    • Gakiopoulou, Harikleia;
    • Briasoulis, Alexandros;
    • Davos, Constantinos H.;
    • Kostomitsopoulos, Nikolaos;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios Athanasios;
    • Terpos, Evangelos;
    • Chłopicki, Stefan;
    • Gavriatopoulou, Maria;
    • Andreadou, Ioanna
    Publication type:
    Article
    3
    4
    5
    6

    Pembrolizumab in endometrial cancer: Where we stand now.

    Published in:
    Oncology Letters, 2021, v. 22, n. 6, p. N.PAG
    By:
    • Aravantinou-Fatorou, Aikaterini;
    • Andrikopoulou, Angeliki;
    • Liontos, Michael;
    • Fiste, Oraianthi;
    • Georgakopoulou, Vasiliki E.;
    • Dimopoulos, Meletios-Athanasios;
    • Gavriatopoulou, Maria;
    • Zagouri, Flora
    Publication type:
    Article
    7
    8
    9

    Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer.

    Published in:
    Nutrients, 2025, v. 17, n. 3, p. 556, doi. 10.3390/nu17030556
    By:
    • Paschou, Stavroula A.;
    • Andrikopoulou, Angeliki;
    • Mili, Nikoletta;
    • Svarna, Anna;
    • Kaparelou, Maria;
    • Stefanaki, Katerina;
    • Dedes, Nikolaos;
    • Liatsou, Efstathia;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Psaltopoulou, Theodora;
    • Kastritis, Efstathios;
    • Zagouri, Flora;
    • Dimopoulos, Meletios-Athanasios;
    • Liontos, Michalis
    Publication type:
    Article
    10

    Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

    Published in:
    OncoTargets & Therapy, 2015, v. 8, p. 1843, doi. 10.2147/OTT.S78254
    By:
    • Giannos, Aris;
    • Filipits, Martin;
    • Zagouri, Flora;
    • Brandstetter, Anita;
    • Tsigginou, Alexandra;
    • Sotiropoulou, Maria;
    • Papaspyrou, Irene;
    • Sergentanis, Theodoros N.;
    • Psaltopoulou, Theodora;
    • Rodolakis, Alexandros;
    • Antsaklis, Aris;
    • Dimopoulos, Meletios-Athanasios;
    • Dimitrakakis, Constantine
    Publication type:
    Article
    11

    The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-149
    By:
    • Stofas, Anastasios;
    • Levidou, Georgia;
    • Piperi, Christina;
    • Adamopoulos, Christos;
    • Dalagiorgou, Georgia;
    • Bamias, Aristotelis;
    • Karadimou, Alexandra;
    • Lainakis, George A.;
    • Papadoukakis, Stefanos;
    • Stravodimos, Konstantinos;
    • Dimopoulos, Meletios-Athanasios;
    • Patsouris, Efstratios;
    • Gakiopoulou, Hariklia;
    • Korkolopoulou, Penelope
    Publication type:
    Article
    12

    The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-149
    By:
    • Stofas, Anastasios;
    • Levidou, Georgia;
    • Piperi, Christina;
    • Adamopoulos, Christos;
    • Dalagiorgou, Georgia;
    • Bamias, Aristotelis;
    • Karadimou, Alexandra;
    • Lainakis, George A.;
    • Papadoukakis, Stefanos;
    • Stravodimos, Konstantinos;
    • Dimopoulos, Meletios-Athanasios;
    • Patsouris, Efstratios;
    • Gakiopoulou, Hariklia;
    • Korkolopoulou, Penelope
    Publication type:
    Article
    13
    14
    15
    16
    17

    Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC).

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 24, p. 5500, doi. 10.1002/cncr.26172
    By:
    • Vassilakopoulou, Maria;
    • de la Motte Rouge, Thibault;
    • Colin, Pierre;
    • Ouzzane, Adil;
    • Khayat, David;
    • Dimopoulos, Meletios-Athanasios;
    • Papadimitriou, Christos A.;
    • Bamias, Aristotle;
    • Pignot, Géraldine;
    • Nouhaud, François Xavier;
    • Hurel, Sophie;
    • Guy, Laurent;
    • Bigot, Pierre;
    • Roumiguié, Mathieu;
    • Rouprêt, Morgan
    Publication type:
    Article
    18

    Small RNA‐seq and clinical evaluation of tRNA‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRF<sup>HisGTG</sup> results in patients' poor treatment outcome.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1790, doi. 10.1111/bjh.19332
    By:
    • Soureas, Konstantinos;
    • Papadimitriou, Maria‐Alexandra;
    • Malandrakis, Panagiotis;
    • Papanota, Aristea‐Maria;
    • Adamopoulos, Panagiotis G.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Liacos, Christine‐Ivy;
    • Gavriatopoulou, Maria;
    • Sideris, Diamantis C.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos;
    • Avgeris, Margaritis
    Publication type:
    Article
    19

    Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 356, doi. 10.1111/bjh.17841
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Fotiou, Despina;
    • Papanagnou, Eleni‐Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios
    Publication type:
    Article
    20

    Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

    Published in:
    British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
    By:
    • Rosiñol, Laura;
    • Beksac, Meral;
    • Zamagni, Elena;
    • Van de Donk, Niels W. C. J.;
    • Anderson, Kenneth C.;
    • Badros, Ashraf;
    • Caers, Jo;
    • Cavo, Michele;
    • Dimopoulos, Meletios‐Athanasios;
    • Dispenzieri, Angela;
    • Einsele, Hermann;
    • Engelhardt, Monika;
    • Fernández de Larrea, Carlos;
    • Gahrton, Gösta;
    • Gay, Francesca;
    • Hájek, Roman;
    • Hungria, Vania;
    • Jurczyszyn, Artur;
    • Kröger, Nicolaus;
    • Kyle, Robert A.
    Publication type:
    Article
    21
    22

    Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques.

    Published in:
    PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009701
    By:
    • Rosati, Margherita;
    • Agarwal, Mahesh;
    • Hu, Xintao;
    • Devasundaram, Santhi;
    • Stellas, Dimitris;
    • Chowdhury, Bhabadeb;
    • Bear, Jenifer;
    • Burns, Robert;
    • Donohue, Duncan;
    • Pessaint, Laurent;
    • Andersen, Hanne;
    • Lewis, Mark G.;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Wlodawer, Alexander;
    • Mullins, James I.;
    • Venzon, David J.;
    • Pavlakis, George N.;
    • Felber, Barbara K.
    Publication type:
    Article
    23

    Response of an oncology unit in the midst of the COVID-19 outbreak.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 1947, doi. 10.1177/1078155220967973
    By:
    • Liontos, Michalis;
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Koutsoukos, Konstantinos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Psaltopoulou, Theodora;
    • Zagouri, Flora;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    24
    25

    Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents.

    Published in:
    Oncology, 2013, v. 84, n. 3, p. 158, doi. 10.1159/000341366
    By:
    • Bamias, aristotle;
    • Bamia, Christine;
    • Zagouri, Flora;
    • Kostouros, Efthimios;
    • Kakoyianni, Konstantina;
    • Rodolakis, alexandros;
    • Vlahos, George;
    • Haidopoulos, Dimitrios;
    • Thomakos, Nikolaos;
    • antsaklis, aris;
    • Dimopoulos, Meletios-athanasios
    Publication type:
    Article
    26

    Precision medicine in gynecological cancer (Review).

    Published in:
    Biomedical Reports, 2025, v. 22, n. 3, p. N.PAG, doi. 10.3892/br.2025.1921
    By:
    • Aravantinou-Fatorou, Aikaterini;
    • Georgakopoulou, Vasiliki Epameinondas;
    • Dimopoulos, Meletios Athanasios;
    • Liontos, Michalis
    Publication type:
    Article
    27
    28

    Clinical perspectives of BET inhibition in ovarian cancer.

    Published in:
    Cellular Oncology (2211-3428), 2021, v. 44, n. 2, p. 237, doi. 10.1007/s13402-020-00578-6
    By:
    • Andrikopoulou, Angeliki;
    • Liontos, Michalis;
    • Koutsoukos, Konstantinos;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    29

    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 687, doi. 10.1016/j.clml.2023.05.004
    By:
    • Sonneveld, Pieter;
    • Richardson, Paul G.;
    • Ludwig, Heinz;
    • Dimopoulos, Meletios-Athanasios;
    • Schjesvold, Fredrik H.;
    • Hajek, Roman;
    • Abdulhaq, Haifaa;
    • Thuresson, Marcus;
    • Norin, Stefan;
    • Bakker, Nicolaas A.;
    • Mateos, Maria-Victoria
    Publication type:
    Article
    30
    31

    P-224: Pomalidomide, bortezomib, and dexamethasone after 1 prior line of therapy in relapsed or refractory multiple myeloma (RRMM): A safety subanalysis of the phase 3 OPTIMISMM trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S163, doi. 10.1016/S2152-2650(21)02351-X
    By:
    • Weisel, Katja;
    • Dimopoulos, Meletios-Athanasios;
    • Oriol, Albert;
    • Beksac, Meral;
    • Dimopoulos, Fredrik;
    • Liberati, Anna Marina;
    • Lindsay, Jindriska;
    • White, Darrell;
    • San-Miguel, Jesús F.;
    • Moreau, Philippe;
    • Anderson Jr., Larry D.;
    • Lorocca, Alessandra;
    • Robak, Pawef;
    • Vogel, Prisca;
    • Jiang, Ruiyun;
    • Grote, Lara;
    • Peluso, Teresa;
    • Richardson, Paul G.
    Publication type:
    Article
    32

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    33

    P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2
    By:
    • Lonial, Sagar;
    • Berdeja, Jesus G.;
    • Dimopoulos, Meletios-Athanasios;
    • Jagannath, Sundar;
    • Knop, Stefan;
    • Hang Quach;
    • Rodríguez-Otero, Paula;
    • Richardson, Paul G.;
    • Sorrell, April;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • Tuong Vi Nguyen;
    • Hong, Kevin;
    • Peluso, Teresa;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    34

    P-204: Carfilzomib, Dexamethasone, and Daratumumab (KdD) vs Kd: subgroup analysis of the CANDOR study by prior autologous stem cell transplantation, Lenalidomide exposure, or Lenalidomide refractory disease.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02331-4
    By:
    • Mateos, María-Victoria;
    • Usmani, Saad Z.;
    • Quach, Hang;
    • Dimopoulos, Meletios-Athanasios;
    • Fonseca, Rafael;
    • McFadden, Ian;
    • Yusuf, Akeem;
    • Khurana, Monica;
    • Obreja, Mihaela;
    • Spencer, Andrew
    Publication type:
    Article
    35

    P-206: SELECT Trial in Progress: an open-label, phase 2 study of Carfilzomib, Pomalidomide, and Dexamethasone in patients with first or second relapse of Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S152, doi. 10.1016/S2152-2650(21)02333-8
    By:
    • Moreau, Philippe;
    • Delimpasi, Sosana;
    • Katodritou, Eirini;
    • Belotti, Angelo;
    • Melear, Jason;
    • Frolund, Ulf;
    • Rosiñol, Laura;
    • Besemer, Britta;
    • Yusuf, Akeem;
    • Khurana, Monica;
    • Zhao Yang;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    36

    P-193: Elotuzumab plus pomalidomide/dexamethasone for relapsed/refractory multiple myeloma: final overall survival from the phase 2 ELOQUENT-3 trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S143, doi. 10.1016/S2152-2650(21)02320-X
    By:
    • Dimopoulos, Meletios-Athanasios;
    • Dytfeld, Dominik;
    • Grosicki, Sebastian;
    • Moreau, Philippe;
    • Takezako, Naoki;
    • Hori, Mitsuo;
    • Leleu, Xavier;
    • LeBlanc, Richard;
    • Suzuki, Kenshi;
    • Raab, Marc;
    • Richardson, Paul G.;
    • McKiver, Mihaela Popa;
    • Ying-Ming Jou;
    • David Yao;
    • Das, Prianka;
    • San-Miguel, Jesús F.
    Publication type:
    Article
    37

    P-191: Comparison of efficacy outcomes for Carfilzomib plus Dexamethasone and Daratumumab (KdD) versus Pomalidomide plus Bortezomib and Dexamethasone (PVd) and D-Pd in relapsed or refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S142, doi. 10.1016/S2152-2650(21)02318-1
    By:
    • Chari, Ajai;
    • Dimopoulos, Meletios-Athanasios;
    • Beksac, Meral;
    • Leleu, Xavier;
    • Weisel, Katja;
    • Richter, Joshua;
    • Dirnberger, Franziska;
    • Iskander, Karim;
    • Yusuf, Akeem;
    • Mikhael, Joseph
    Publication type:
    Article
    38

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    39

    P-059: miRNA profiling of CD138+ plasma cells identifies miR-181a-5p overexpression as independent predictor of short-term progression and poor treatment outcome in multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S71, doi. 10.1016/S2152-2650(21)02193-5
    By:
    • Papadimitriou, Maria-Alexandra;
    • Papanota, Aristea-Maria;
    • Adamopoulos, Panagiotis;
    • Pilala, Katerina-Marina;
    • Liacos, Christine-Ivy;
    • Malandrakis, Panagiotis;
    • Mavrianou-Koutsoukou, Nefeli;
    • Patseas, Dimitrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Avgeris, Margaritis;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Scorilas, Andreas
    Publication type:
    Article
    40

    OAB-050: OCEAN (OP-103): a Phase 3, randomized, global, head-to-head comparison study of Melflufen and Dexamethasone (Dex) versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S32, doi. 10.1016/S2152-2650(21)02124-8
    By:
    • Schjesvold, Fredrik;
    • Dimopoulos, Meletios-Athanasios;
    • Delimpasi, Sosana;
    • Robak, Pawef;
    • Coriu, Daniel;
    • Legiec, Wojciech;
    • Pour, Ludek;
    • Špicka, Ivan;
    • Masszi, Tamás;
    • Doronin, Vadim;
    • Minarik, Jiri;
    • Salogub, Galina;
    • Alexeeva, Yulia;
    • Lazzaro, Antonio;
    • Maisnar, Vladimir;
    • Mikala, Gábor;
    • Moody, Victoria;
    • Thuresson, Marcus;
    • Byrne, Catriona;
    • Harmenberg, Johan
    Publication type:
    Article
    41

    OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S23, doi. 10.1016/S2152-2650(21)02110-8
    By:
    • Muchtar, Eli;
    • Wisniowski, Brendan;
    • Palladini, Giovanni;
    • Milani, Paolo;
    • Merlini, Giampaolo;
    • Schönland, Stefan;
    • Veelkan, Kaya;
    • Hegenbart, Ute;
    • Dispenzieri, Angela;
    • Kumar, Shaji;
    • Leung, Nelson;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Liedtke, Michaela;
    • Witteles, Ronald;
    • Sanchorawala, Vaishali;
    • Szalat, Raphael;
    • Landau, Heather;
    • Lentzsch, Suzanne;
    • Bladé, J
    Publication type:
    Article
    42

    OAB-038: Graded cardiac response criteria for AL amyloidosis: the impact of depth of cardiac response on survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02112-1
    By:
    • Muchtar, Eli;
    • Dispenzieri, Angela;
    • Wisniowski, Brendan;
    • Palladini, Giovanni;
    • Milani, Paolo;
    • Merlini, Giampaolo;
    • Schönland, Stefan;
    • Veelkan, Kaya;
    • Hegenbart, Ute;
    • Kumar, Shaji;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Liedtke, Michaela;
    • Witteles, Ronald;
    • Sanchorawala, Vaishali;
    • Szalat, Raphael;
    • Landau, Heather;
    • Lentzsch, Suzanne;
    • Coltoff, Alexander;
    • Blade, Joan
    Publication type:
    Article
    43

    MM-408: The Assessment of Stem Cell Graft Contamination via Next-Generation Flow Cytometry Serves as a Negative Predictor for Deep Remissions Post-Autologous Stem Cell Transplantation in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S441, doi. 10.1016/S2152-2650(21)01982-0
    By:
    • Kostopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Panteli, Chrisanthi;
    • Malandrakis, Panagiotis;
    • Kanelias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migou, Magdalini;
    • Liakos, Christina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    44

    Poster: MM-408: The Assessment of Stem Cell Graft Contamination via Next-Generation Flow Cytometry Serves as a Negative Predictor for Deep Remissions Post-Autologous Stem Cell Transplantation in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S253, doi. 10.1016/S2152-2650(21)01584-6
    By:
    • Kostopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Panteli, Chrisanthi;
    • Malandrakis, Panagiotis;
    • Kanelias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migou, Magdalini;
    • Liakos, Christina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    45
    46

    Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

    Published in:
    2019
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papasotiriou, Ioannis;
    • Fotiou, Despoina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios;
    • Dialoupi, Ioanna;
    • Eleutherakis Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    journal article
    47

    Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S249, doi. 10.1016/j.clml.2018.07.149
    By:
    • Jagannath, Sundar;
    • Vogl, Dan T.;
    • Dimopoulos, Meletios-Athanasios;
    • Nooka, Ajay;
    • Huff, Carol;
    • Moreau, Philippe;
    • Cole, Craig;
    • Richter, Josh;
    • Dingli, David;
    • Vij, Ravi;
    • Tuchman, Sascha;
    • Raab, Marc-Steffen;
    • Weisel, Katja;
    • Delforge, Michel;
    • Kaminetzky, David;
    • Cornell, Robert Frank;
    • Stewart, A. Keith;
    • Hoffman, James;
    • Godby, Kelly N.;
    • Parker, Terri Lynn
    Publication type:
    Article
    48
    49

    A Revised Staging System for Waldenström's Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S332, doi. 10.1016/j.clml.2017.07.146
    By:
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Kyrtsonis, Marie Christine;
    • Hatjiharissi, Evdoxia;
    • Katodritou, Eirini;
    • Repousis, Panagiotis;
    • Symeonidis, Argiris;
    • Michael, Michalis;
    • Pouli, Anastasia;
    • Giannakoulas, Nikolaos;
    • Christoulas, Dimitrios;
    • Megalakaki, Aikaterini;
    • Tsirigotis, Panagiotis;
    • Giannouli, Stavroula;
    • Panagiotidis, Panagiotis;
    • Vervessou, Elina;
    • Spanoudakis, Emmanouil;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    50